Embryofetopathy due to oral anticoagulant therapy (Q46697): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-LD2F.02 | |||
| Property / Canary Token: dki-india-LD2F.02 / rank | |||
Normal rank | |||
Revision as of 15:28, 13 August 2026
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | LD2F.02 |
||
| English | Embryofetopathy due to oral anticoagulant therapy |
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia. |
Statements
CID11:LD2F.02
0 references
dki-india-LD2F.02
0 references
